Biosimilar Insulins

  • 4.5 (839)

Enrolled: 2895 Learners

Views: 31130

Time: 60 mins

About this course

This course provides the latest advanced guidelines on the availability of affordable insulin options and the effective use of biosimilar to prevent damages in diabetes management and promote self-management. It provides an understanding of the basics of biosimilars, the general principles of demonstrating biosimilarity and the integration of biosimilar insulin into clinical practice.


You must complete all the sections of this online course to be awarded the IDF “Certificate of Completion” and one European CME credit.


CME Accreditation

The European Accreditation Council accredits this online course for Continuing Medical Education (EACCME). 1 European CME credit (ECMEC®) will be awarded on successful completion of this course.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at

Learners Reviews


Average Rating

(839 ratings)
  • 59%
  • 34%
  • 6%
  • 1%
  • 0%

Additional Contributors

Lina Xue, Tanu Soni, Sameer Pathan, Xangô Bimont, Margaux Ysebaert, Adilson Randi, Lorenzo Piemonte

Course Development Support

This online module is supported by an educational grant from

Technical Design and Development
Technical Design and Developmen

Frequently Asked Questions (FAQ)

Course Details


Course Duration:

60 minutes of self-paced learning to be completed within a month of enrolment.

Course Fees:




Assessment & Awards:

Complete all the sections of this online course to be awarded with an IDF "Certificate of Completion" and one European CME credit

This online module is supported by

© 2022 - IDF - All Right Reserved | Privacy Policy